Gaomei Chang

Shanghai, 200120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Corrigendum to "Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma" [Arch. Biochem. Biophys. 754 (2024) 109929].

Corrigendum to "Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma" [Arch. Biochem. Biophys. 754 (2024) 109929].

Journal: Archives of biochemistry and biophysics

Published: October 29, 2025

Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma.

Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma.

Journal: Archives of biochemistry and biophysics

Published: December 07, 2023

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma.

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma.

Journal: Frontiers in immunology

Published: May 10, 2023

Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression.

Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression.

Journal: Acta biochimica et biophysica Sinica

Published: March 25, 2018

PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1.

PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1.

Journal: Acta biochimica et biophysica Sinica

Published: November 16, 2017

DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.

DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.

Journal: Cell death & disease

Published: June 08, 2017

Pterostilbene Induces Cell Apoptosis and Cell Cycle Arrest in T-Cell Leukemia/Lymphoma by Suppressing the ERK1/2 Pathway.

Pterostilbene Induces Cell Apoptosis and Cell Cycle Arrest in T-Cell Leukemia/Lymphoma by Suppressing the ERK1/2 Pathway.

Journal: BioMed research international

Published: February 12, 2017

Dihydrocelastrol inhibits multiple myeloma cell proliferation and promotes apoptosis through ERK1/2 and IL-6/STAT3 pathways in vitro and in vivo.

Dihydrocelastrol inhibits multiple myeloma cell proliferation and promotes apoptosis through ERK1/2 and IL-6/STAT3 pathways in vitro and in vivo.

Journal: Acta biochimica et biophysica Sinica

Published: December 29, 2016

The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells.

The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells.

Journal: Oncology reports

Published: December 13, 2016

Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma.

Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma.

Journal: Theranostics

Published: November 14, 2016

Pterostilbene Inhibits Human Multiple Myeloma Cells via ERK1/2 and JNK Pathway In Vitro and In Vivo.

Pterostilbene Inhibits Human Multiple Myeloma Cells via ERK1/2 and JNK Pathway In Vitro and In Vivo.

Journal: International journal of molecular sciences

Published: September 22, 2016

Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells.

Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells.

Journal: Scientific reports

Published: August 17, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026